Jan 10, 2012
Dr. Kongnara Papankorn and Dr. Sarah Molokhia will present on behalf of Aciont Inc at the Global Technology Community’s 4th Ocular & Drug Discovery Conference, February 27-28, 2012, in Las Vegas, NV.
Apr 26, 2011
Aciont’s poster “Importance of the Conjunctiva in Transscleral Iontophoresis” will be shown on May 3, 2011 at the meeting.
Feb 08, 2011
John Higuchi will present on behalf of Aciont Inc at the IN3 West Medical Device Conference in Las Vegas, NV on February 22, 2011.
Nov 04, 2010
Aciont Inc. receieves a total of $489K in grants for two ongoing ophthalmology projects
Jul 06, 2010
Aciont is awarded a phase I SBIR $214K grant for the project titled “Novel Method for the Ocular Iontophoretic Delivery of Avastin® and Lucentis®”
Jun 08, 2010
John Higuchi will present on behalf of Aciont Inc at the IN3 East Medical Device Conference in Boston, MA on June 10, 2010.
Apr 09, 2010
Aciont’s poster “Transscleral Passive Delivery of Rapamycin in Rabbit Using a Visulex Topical Application Device” will be shown on May 6, 2010 at the meeting.
Apr 02, 2010
Balbir Brar brings 25 years of drug and device development experience to Aciont Inc.
Dec 10, 2009
The National Eye Institute (NEI) awarded a $2.18 million grant to Aciont Inc. to help fund its development of a non-invasive, passive diffusion-based treatment for severe, non-infectious uveitis.